GammaTile consists of radioactive sources embedded in a collagen matrix. Placed in the cavity created by the removal of a brain tumor, the device delivers radiation therapy to eliminate any cancer cells that are still in the area after surgery. The Food and Drug Administration cleared the device for use in recurrent cancers in 2018 and expanded the label to cover newly diagnosed malignant tumors in 2020. READ MORE